Rosabulin

DB20161InvestigationalSmall molecule

Rosabulin is a small molecule drug. Rosabulin is under investigation in clinical trial NCT00276913 (A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors). Rosabulin has... Rosabulin has a monoisotopic molecular weight of 400.1 Da.

Formula / weight: C₂₂H₁₆N₄O₂S · 400.46 g/mol (avg)
Code names: STA-5312

Resolves to

Compound

UNII6Z674O12T6CAS501948-05-6ChEMBLCHEMBL271068ChEBI748858PubChem9843935

Structure

InChIKeyIZZYUABKZYIINT-UHFFFAOYSA-NSMILESCC1=NSC(NC(=O)C(=O)C2=C3C=CC=CN3C(CC3=CC=C(C=C3)C#N)=C2)=C1

What you can answer from here — as of September 23, 2026

2Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of Rosabulin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account